My education has been quite eclectic. I completed a BSc in Chemical Biology, with minor in Developmental Psychology, Gender Psychology, and Abnormal Psychology, from Stevens Institute of Technology (Hoboken, NJ). I followed this with a Masters degree in Counseling Psychology from Argosy University (Chicago, IL).

1. Shetty V, Dar S, Hussaini S, Alvi S, Span L, Mundle S, Gezer S, Vellugopal P, Rilles C, Chopra H, Borok R, Robin E, Rifkill S, Alstoll D, Hernandez B, Hsu WT, Priesler H: Effect of anti-phosphatidic drugs on the expression of cytokines in Myelodysplastic Syndromes (MDS). Exptl Hematol 24(9): 1129, abstr #573, 1996.

2. Mundle SD, Cartlidge J, Vellugopal P, Gezer S, Rilles C, Gregory SA, Alvi S, Shetty V, Borok R, Showel M, Hussaini S, Dar S, Robin EL, Rifkill SD, Alstoll D, Hernandez BM, Shah R, Raza A: Multiple DNA fragmentation patterns in spontaneous apoptotic death of bone marrow cells and enhancement of all in myelodysplastic syndromes. Proc of the American Society of Hematology 38th Annual Meeting. Blood 88(10) Suppll(Part 2 of2):208b, Abst #3558, 1996.

3. Shetty V, Hussaini S, Broady-Robillsoll L, Gao X, Dar S, Mundle S, Cartlidge J, Bagal K, Showe.l M, Alldrews C, Akhtar A, Ali A, Mativi BY, Vellugopa.l P, Chopra H, Bi S, Gregory SA, Preisler H, Raza A: Suppression of tumor necrosis factor-alpha (TNF-a) induced apoptosis by Flt-3 Ligand in myelodysplastic syndromes (MDS) and HL-60 cells. Proc Am Soc Hematol, Blood 90(10):203a, abstr #894,1997.

4. Hussaini S, Shetty V, Broady-Robillsoll L, Gezer S, Dar S, Akhtar A, Showel M, Cartlidge J, Mundle S, Ali A, Mativi BY, Vellugopal P, Rilles C, Raza A: Detection of myeloid cells in S-phase using double labeling for myeloperoxidase (MPO) and iodoexyuridine (IudR) in patients with myelodysplastice syndromes (MDS). Proc Am Soc Hematol, Blood 90(10):287b, abst #4039,1997.

5. Shetty V, Allampallam K, Hussaini S, Ali A, Mundle S, Akhtar A, Cartlidge J, Mativi B, Qawi H, Vellugopal P, Raza A: Absence of Flt-3 ligand co-relates with high incidences of apoptosis in myelodysplasticsyndromes. Proc Am Assoc Cancer Research; 39:142-143, Abst #973,1998.

6. Ali A, Ragasa D, Reza S, Shetty V, Broady-Robillsoll L, Hussaini S, Cartlidge J, Mundle S, Mativi BY, Qawi H, Ali SI, Dar S, Alldric T, Raza A: Relationship between caspase-3- like protease activity, tumor necrosis factor a and proliferation index in bone marrows of patients with myelodysplastic syndromes (MDS). Submitted to the 34th Annual Meeting of the American Society of Clinical Oncology, Los Angeles, California, 1998.

7. Allampallam K, Shetty V, Hussaini S,Broady-Robillsoll L, Showel M, Cartlidge J, Mundle S, Ali A, Qawi H, Vellugopal P, Raza A: Profile of cytokines in myelodysplatic syndrome (MDS) bone marrow. Submitted to the Cell Proliferation Society, 1998.

8. Mativi BY, Mundle S, Feldmall G, Reza S, Shetty V, Ali SI, Hussaini S, Broady-Robillsoll L, Allampallam K, Vellugopal P, Qawi H, Gregory SA, Raza A: Expression ofmRNA for human cytomegalovirus (CMV) major immediate early protein correlates with apoptosis and presence of tumor necrosis factor alpha (TNFa) in myelodysplastic bone marrows. Proc Am Soc Hematol, Blood 92(10):153b, abstr #3632, 1998.

9. Shetty V, Allampallam K, Hussaini S, Mundle S, Reza S, Cartlidge J, broady-Robillsoll L, Li B, huang R- W, Mazzorall L, Mahmud W, Broderick E, Townsend W, Yakoob S, Gundroo A, Mativi B, Qawi H, Lisak L, Preisler H, Raza A: Pro- and anti-apoptotic cytokines and the incidence of apoptosis in newly diagnosed cases of myelodysp[lastic syndromes (MDS). Proc Am Soc Hematol, Blood 92(10):160b, abstr #3664, 1998.

10. Allampallam K, Shetty V, Dar S, Hussaini S, Cartlidge J, Broderick E, Townsend W, Qawi H, Mazzoran L, Mahmud W, Mundle S, Reza S, Gundroo A, Yakoob S, Broady-Robinson L, Preisler H, Raza A: Elevated levels of serum tumor necrosis factor receptors in myelodysplastic syndrome' (MDS). Proc Am Soc Hematol, Blood 92(10):422a, abstr #1743, 1998.

11. Raza A, Allampallam K, Shetty V, Mundle S, Borok R, Lisak L, Andrews C, Ekbal M, M~zzoran L, Zorat F, Henderson B, Dangerfield B, Ansaarie I, Hussaini S, Broady- Robinson L, Venugopal P: Biologic and clinical response to recombinant human soluble tumor necrosis factor receptor (Enbrel) in patients with myelodysplastic syndromes (MDS). Proc Am Soc Hematol, Blood 94(10):171b, abstr# 3941,1999.

12. Shetty V, Hussaini S, Broady-Robinson L, Allampallam K, Ansaari I, Holtzclaw J, Mundle S, Mazzoran L, Zorat F, Payne C, Raza A: Ultrastructural evidence of previously unreported excessive apoptosis in high density bone marrow (BM) cells of myelodysplastic syndrome (MDS) patients. Proc Am Soc Hematol, Blood 94(10):287b, abstr# 4499,1999.

13. Allampallam K, Shetty V, Hussaini S, Mazzoran L, Akber A, Zorat F, Deobhakta A, Huang R, Raza A: Changes in cytokine and receptro transcript levels in bone marrows of patients with myelodysplastic syndromes. Proc Am Soc Hematol, Blood 94(10):282b, abstr# 4475,1999.

14. Dar S, Mundle S, Andric T, Qawi H, Shetty V, Reza S, Mativi BY, Allampallam K, Ali A, Venugopal P , Gezer S, Broady-Robinson L, Cartlidge J, Showel M, Hussaini S, Ragasa D, Ali I, Chaudhry A, Waggoner SI Lisak L, Raza A: Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis. Eur J Haematol:62(2):90-94, 1999.

15. Shetty V, Hussaini S, Broady-Robinson L, Allampallam K, Mundle S, Borok R, Cartlidge J, Broderick E, Mazzoran L, Zorat F, Raza A: Intramedullar apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high density fraction of bone marrow aspirates. Submitted to Blood, 1999.

16. Allampallam K, Shetty V, Hussaini S, Mazzoran L, Zorat F, Huang R, Raza A: Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic sy".dromes. Anticancer Research, 2000.

17. Mazzoran L, Dangerfield B, Zorat F, Townsend W, Hussaini S, Shetty V, Mundle S, Allampallam K, Yakoob S, Gundroo A, Dar S, Ansaarie I, Andrews C, Lisak L, Raza A: Morphologically/ultrstructurally normal but increased number of macrophages in myelodysplastic syndromes. Submitted to Clinical and Laboratory Haematology, 2000.